Robin Lee1, Karen Dahri2, Tim T Y Lau3, Stephen Shalansky4. 1. , BSc, is a student in the Faculty of Pharmaceutical Sciences (Class of 2018), The University of British Columbia, Vancouver, British Columbia. 2. , BSc, BSc(Pharm), PharmD, ACPR, is a Clinical Pharmacotherapeutic and Research Specialist in Internal Medicine, Pharmaceutical Sciences, Vancouver General Hospital, and is also an Assistant Professor (Partner) with the Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia. 3. , PharmD, is a Clinical Supervisor and Pharmacotherapeutic Specialist in Infectious Diseases, Pharmaceutical Sciences, Vancouver General Hospital, and is also a Clinical Professor with the Faculty of Pharmaceutical Sciences and an Associate Member in the Division of Infectious Diseases, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia. 4. , BSc(Pharm), ACPR, PharmD, FCSHP, is Clinical Coordinator of the Pharmacy Department, Providence Healthcare, Lower Mainland Pharmacy Services, and is a Clinical Professor with the Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia. He is also the Editor of the Canadian Journal of Hospital Pharmacy.
Abstract
BACKGROUND: Few studies have attempted to determine the proportion of Canadian hospital pharmacists involved in clinical research, despite a general consensus that research should be an essential component of a pharmacist's professional role. OBJECTIVES: The primary objective was to characterize the involvement in clinical pharmacy research of hospital pharmacists in the 4 health authorities of the Lower Mainland of British Columbia (collectively known as the Lower Mainland Pharmacy Services). The secondary objective was to identify perceived barriers to conducting research. METHODS: Pharmacists employed within Lower Mainland Pharmacy Services were invited to participate in an online cross-sectional survey, for completion in August and September 2015. Descriptive statistics were used to analyze the results. Groups of survey participants were compared to examine differences in measured outcomes. RESULTS: A total of 534 pharmacists were surveyed, with a response rate of 16% (85/534). Overall, 77% (55/71) of the respondents reported having participated in research, and 87% (62/71) expressed interest in conducting future research. Chart reviews (78%, 36/46) and surveys (41%, 19/46) were the most common study designs used in prior research. Participants self-identified their research-related strengths as literature evaluation (46%, 27/59) and hypothesis generation (44%, 26/59). Conversely, 81% (48/59) of respondents self-identified statistical analysis as a weakness. Most respondents stated that personal satisfaction (82%, 49/60) and the opportunity to learn about disease states (78%, 47/60) were the driving factors for conducting research. The most commonly cited barrier to conducting research was lack of time (92%, 55/60). Opportunities to join existing teams (73%, 44/60) and mentorship programs (70%, 42/60) were identified as the most popular arrangements for encouraging future research. CONCLUSIONS: Most of the pharmacists who responded to this survey reported having participated in clinical pharmacy research, but a lack of dedicated time appears to be a major hurdle to greater research participation. A targeted program increasing exposure to existing research teams and mentorship opportunities is recommended for promoting future research.
BACKGROUND: Few studies have attempted to determine the proportion of Canadian hospital pharmacists involved in clinical research, despite a general consensus that research should be an essential component of a pharmacist's professional role. OBJECTIVES: The primary objective was to characterize the involvement in clinical pharmacy research of hospital pharmacists in the 4 health authorities of the Lower Mainland of British Columbia (collectively known as the Lower Mainland Pharmacy Services). The secondary objective was to identify perceived barriers to conducting research. METHODS: Pharmacists employed within Lower Mainland Pharmacy Services were invited to participate in an online cross-sectional survey, for completion in August and September 2015. Descriptive statistics were used to analyze the results. Groups of survey participants were compared to examine differences in measured outcomes. RESULTS: A total of 534 pharmacists were surveyed, with a response rate of 16% (85/534). Overall, 77% (55/71) of the respondents reported having participated in research, and 87% (62/71) expressed interest in conducting future research. Chart reviews (78%, 36/46) and surveys (41%, 19/46) were the most common study designs used in prior research. Participants self-identified their research-related strengths as literature evaluation (46%, 27/59) and hypothesis generation (44%, 26/59). Conversely, 81% (48/59) of respondents self-identified statistical analysis as a weakness. Most respondents stated that personal satisfaction (82%, 49/60) and the opportunity to learn about disease states (78%, 47/60) were the driving factors for conducting research. The most commonly cited barrier to conducting research was lack of time (92%, 55/60). Opportunities to join existing teams (73%, 44/60) and mentorship programs (70%, 42/60) were identified as the most popular arrangements for encouraging future research. CONCLUSIONS: Most of the pharmacists who responded to this survey reported having participated in clinical pharmacy research, but a lack of dedicated time appears to be a major hurdle to greater research participation. A targeted program increasing exposure to existing research teams and mentorship opportunities is recommended for promoting future research.
Authors: S H Simpson; J A Johnson; C Biggs; R S Biggs; A Kuntz; W Semchuk; J G Taylor; K B Farris; R T Tsuyuki Journal: Pharmacotherapy Date: 2001-06 Impact factor: 4.705
Authors: Susan C Fagan; Daniel Touchette; Judith A Smith; Kevin M Sowinski; Lisa Dolovich; Kari L Olson; Kai I Cheang; Jill M Kolesar; M Lynn Crismon Journal: Pharmacotherapy Date: 2006-07 Impact factor: 4.705
Authors: Thomas C Dowling; John E Murphy; James S Kalus; Nancy T Nkansah; Jill S Chappell; Nathan P Wiederhold; Paul Beringer; Kristine R Crews; Jodi L Grabinski; Ronald P Evens; Richard Leff Journal: Pharmacotherapy Date: 2009-02 Impact factor: 4.705
Authors: Samuel M Poloyac; Kerry M Empey; Lisa C Rohan; Susan J Skledar; Philip E Empey; Thomas D Nolin; Robert R Bies; Robert B Gibbs; Maggie Folan; Patricia D Kroboth Journal: Am J Pharm Educ Date: 2011-03-10 Impact factor: 2.047
Authors: Derek Stewart; Moza Al Hail; P V Abdul Rouf; Wessam El Kassem; Lesley Diack; Binny Thomas; Ahmed Awaisu Journal: Int J Clin Pharm Date: 2015-03-03
Authors: Marc M Perreault; Zoé Thiboutot; Lisa D Burry; Louise Rose; Salmaan Kanji; Jaclyn M LeBlanc; Roxane R Carr; David R Williamson Journal: Ann Pharmacother Date: 2012-08-28 Impact factor: 3.154
Authors: Kathryn A Morbitzer; Jacqueline E McLaughlin; Aaron S Devanathan; Sachiko Ozawa; Mary R McClurg; Delesha M Carpenter; Craig R Lee Journal: J Am Coll Clin Pharm Date: 2021-03-13